News of Note—Russian trolls, AstraZeneca's FluMist and more


Here is some other vaccine news of note for the week:

> Russian trolls and social media bots used Twitter to spread false information about vaccines ahead of the 2016 U.S. presidential election, a new study found. Release

> The CDC endorsed AstraZeneca's FluMist for the upcoming flu season after recommending against its use for the two prior seasons. A committee recommended the nasal vaccine for the upcoming season in February. CIDRAP News article

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.

> After health officials decided pregnant women shouldn't receive an experimental Ebola vaccine during an outbreak in the Democratic Republic of Congo, experts wrote an editorial in Stat calling for a reversal of the decision. Stat editorial